Are you Dr. Petersdorf?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 95 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000
Summary
- Dr. Effie Petersdorf, MD is a hematologist in Seattle, Washington. She is currently licensed to practice medicine in Washington. She is affiliated with Fred Hutch Cancer Center and UW Medicine/University of Washington Medical Center.
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 1985 - 1988
- University of WashingtonResidency, Internal Medicine, 1982 - 1985
- McGill University Faculty of MedicineClass of 1982
Certifications & Licensure
- WA State Medical License 1983 - 2026
Publications & Presentations
PubMed
- Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemia.Corentin Orvain, Filippo Milano, Eduardo Rodríguez-Arbolí, Megan Othus, Effie W Petersdorf
Leukemia. 2024-12-12 - 1 citationsDecreasing chronic graft-versus-host disease rates in all populations.Paul A Carpenter, Ted A Gooley, Julie Boiko, Catherine J Lee, Lauri M Burroughs
Blood Advances. 2024-11-26 - A Tool for the Assessment of HLA-DQ Heterodimer Variation in Hematopoietic Cell Transplantation.Ray W Sajulga Jr, Yung-Tsi Bolon, Martin J Maiers, Effie W Petersdorf
Transplantation and Cellular Therapy. 2024-11-01
Press Mentions
- Dr. Fred Appelbaum Receives Lifetime Achievement AwardFebruary 20th, 2023
- New Genetic Clues to Why Most Bone Marrow Transplant Patients Develop Graft-Versus-Host DiseaseSeptember 4th, 2012
Grant Support
- Clinical Significance Of MHC Haplotypes In HCTNational Cancer Institute2003–2012
- Genetic Mechanisms Of Survivorship Disparities After Unrelated HCTNational Cancer Institute2011
- Hematopoietic Stem Cell And Cord Blood TransplantationNational Institute Of Allergy And Infectious Diseases2010–2011
- Immunogenetics Of Graft-Versus-Host DiseaseNational Cancer Institute2007–2011
- Hematopopietic Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2006–2009
- Clinical Significance Of MHC Haplotypes In Hematopoietic Cell TransplantationNational Cancer Institute2007
- Hematopoietic Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2005
- SNPS In Lung Cancer Risk And Therapeutic ResponseNational Cancer Institute2003–2004
- Optimizing BMT For Cancer By Genetic Matching Of DonorsNational Cancer Institute1997–2003
- Immune Deviation Or Tolerance Induced By Human Lymphoid DendriticNational Institute Of Allergy And Infectious Diseases2002
- Functional Genomic Markers In Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2002
- Identification Of Peptide Ligands Responsible For GVHDNational Institute Of Allergy And Infectious Diseases1996–1999